chr5-157098871-T-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032782.5(HAVCR2):c.509A>T(p.Asp170Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000197 in 1,613,122 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032782.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152096Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000339 AC: 85AN: 250988Hom.: 1 AF XY: 0.000258 AC XY: 35AN XY: 135640
GnomAD4 exome AF: 0.000189 AC: 276AN: 1460908Hom.: 3 Cov.: 30 AF XY: 0.000194 AC XY: 141AN XY: 726786
GnomAD4 genome AF: 0.000276 AC: 42AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.000242 AC XY: 18AN XY: 74416
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
- -
not specified Uncertain:1
The c.509A>T (p.D170V) alteration is located in exon 4 (coding exon 4) of the HAVCR2 gene. This alteration results from a A to T substitution at nucleotide position 509, causing the aspartic acid (D) at amino acid position 170 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at